Clinical Trial Update: A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin [Phase 3]

View source ↗

Summary

A Phase 3 trial in esophageal cancer comparing nivolumab plus ipilimumab, or nivolumab with fluorouracil plus cisplatin, against fluorouracil plus cisplatin alo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• FLUOROURACIL (Fluorouracil)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Various Advanced Cancer | Phase 3 | Status: COMPLETED | Results posted: 2022-03-02